Status:
COMPLETED
Primary Care Referrals to Community-based Lifestyle Programs for Management of Obesity
Lead Sponsor:
Mayo Clinic
Conditions:
Obesity
Lifestyle, Healthy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purposes of this study is to evaluate the feasibility of providing a community based referral to Mayo Clinic Employee and Community Health patients for weight loss.
Eligibility Criteria
Inclusion
- Patients who are between 18-65 years of age
- Patients who have a BMI between 25-39.9 kg/m2
- Ability to provide informed consent
- Ability to complete the Diabetes Prevention Program including dietary and physical activity recommendations
- Motivated to lose weight (assessed to be in the preparation or action stage)
Exclusion
- Have used weight loss medications or participated in a weight loss program within the past 30 days.
- Are currently enrolled in DPP or other ExercisAbilities weight loss programs
- Are currently taking supplements known to affect weight.
- Have had weight fluctuations of 20 pounds or more in the past 6 months (EMR check and self-report)
- Have an active untreated clinically significant psychiatric condition (psychosis, bipolar disorder, or depression)
- Are currently pregnant or breastfeeding, or are of child-bearing potential and are likely to become pregnant during the study (within the next 4 months following enrollment)
- Have a history in the past 4 months of any major cardiovascular events including heart valve disease, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease
- Have current uncontrolled hypertension (systolic \> 160 mm Hg or diastolic \> 95 mm Hg) documented on 2 separate occasions
- Have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as diabetes) or active cancer or are within 1 year of cancer remission
- Have a known history of any condition or factor judged by the investigator/study team to preclude participation in the study or which might hinder adherence
- Have any co-morbidity that is deemed exclusionary at the discretion of the provider.
Key Trial Info
Start Date :
September 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04433806
Start Date
September 21 2020
End Date
May 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905